With no news for a while, I guess this one will head slowly lower. Traders selling on the approval, taking good profits off the table, and freeing capital up (other short-term gains await).
Best thing for the true believers to do is not to sell. This is a long-term play, not a short-term trade.
The first Ropren sales are still months away, so everybody hold tight.